Press realease


The ImaSpiiR-X consortium receives support from France 2030 to improve through medical imaging management of cancer and cardiovascular diseases

France 2030 has announced its support for the ImaSpiiR-X consortium, providing �18.2 million in funding over 60 months to move from black-and-white X-ray medical imaging (which displays only tissue density) to full-colour spectral imaging (capable of identifying tissue composition). To achieve this, the consortium will develop next-generation flat-panel detectors that will provide enriched digital radiographic images, along with advanced analysis algorithms.

France 2030 has announced its support for the ImaSpiiR-X consortium, providing �18.2 million in funding over 60 months to move from black-and-white X-ray medical imaging (which displays only tissue density) to full-colour spectral imaging (capable of identifying tissue composition). To achieve this, the consortium will develop next-generation flat-panel detectors that will provide enriched digital radiographic images, along with advanced analysis algorithms.

ImaSpiiR-X will help physicians in real time to perform more comprehensive and accurate diagnoses, better guide their procedures with the assistance of an advanced imaging system, and therefore save precious minutes in patient care. This is particularly crucial for certain critical conditions such as strokes (cerebrovascular accidents), during which two million neurons are lost every minute. Strokes are the leading cause of disability and the third-leading cause of death in France.

ImaSpiiR-X brings together key national players from industry and academia: Trixell, the project coordinator, CEA, Thales, Pyxalis, and Claude Bernard University Lyon 1. Located in the Rh?ne-Alpes region within the world-class competitiveness clusters of Minalogic and Lyonbiop?le, they complement each other by providing the necessary expertise in materials, semiconductors, electronics, and algorithms, with breakthrough technologies serving the medical community. These five partners will oversee the technological development of the project, preclinical validations, and industrial optimisation for the commercialisation of spectral flat-panel detectors. They will also rely on a team of international medical experts.

This project will strengthen the French ecosystem, a global leader in interventional radiology and real-time image-guided surgery, while improving the quality of care provided to patients. The flat-panel detectors resulting from this collaboration will be manufactured in France, with the majority of supplies sourced from more than 200 French suppliers

Published on March 26, 2025